webinar register page

Geopolitics and the vaccine
By the end of 2020, vaccine manufacturers had moved with surprising speed. Trials reported impressive results, and several vaccines have now been approved by regulators. Vaccinations offer the only reliable route out of the COVID-19 emergency, with its attendant threats to health systems, economies, livelihoods and government budgets.

Although there have been international efforts to ensure that poorer states can access vaccines, countries with the capacity to manufacture these vaccines and those with the greatest financial resources have gained an advantage over the rest.

Some, but not all, of these countries have made rapid progress in vaccinating their own populations. With the costs of COVID-19 increasing daily, the imperative for the have-nots to acquire scarce doses is increasing - and with it the diplomatic power of those who have vaccines in hand.

Join the Oxford Analytica team for a webinar to examine the geopolitics of vaccines and the challenges facing governments in accessing treatments, planning the rollout and persuading sceptical publics.

By attending this webinar, you will be able to answer these questions:

- Which vaccines and which countries and companies will help facilitate the developing world’s exit from COVID-19 and what is a realistic timescale?
- Securing a vaccine supply will be only the first of several hurdles. Which countries will face further challenges?
- What risks do richer countries face in prioritising their own full economic reopening over giving assistance to poorer nations?

A discussion between:

Katerina Fytatzi, Senior Analyst, Oxford Analytica
Joydeep Sen, Analyst, Oxford Analytica
Benjamin Charlton, Senior Analyst, Oxford Analytica
John MacLeod, Senior Analyst, Oxford Analytica
Chair: Nick Redman, Editor in Chief and Director of Analysis, Oxford Analytica

Please note, only corporate email addresses will be accepted.

Apr 29, 2021 03:00 PM in London

Webinar logo
* Required information
Loading

By registering, I agree to the Privacy Statement and Terms of Service.

Register